Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection.

Anna CoghillJulian SanchezSweta SinhaJennifer B PermuthDanielle LaskowitzBenjamin D Powers Sean P Dineen

Published in: Cancer reports (Hoboken, N.J.) (2022)

This study demonstrates that CRS/HIPEC can be performed in PHIV without prohibitive complications and operative recovery approximates that of non-HIV patients. Though more study is needed, HIV should not preclude a patient from being offered CRS/HIPEC.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
end stage renal disease
hepatitis c virus
hiv testing
minimally invasive
chronic kidney disease
ejection fraction
newly diagnosed
men who have sex with men
prognostic factors
locally advanced
percutaneous coronary intervention